Human papillomavirus (HPV) is the most common sexually transmitted virus, and is causally
related to several cancers. HPV vaccination rates are far below HealthyPeople 2020 targets …

Human papillomavirus (HPV) represents the most prevalent sexually transmitted infection in
the United States. Despite readily available safe and effective vaccines and established …

Objectives: Despite cancer prevention benefits associated with the human papillomavirus
(HPV) vaccine, uptake in the United States is relatively low among males and females. Our …

Objectives Although racial and ethnic differences in HPV vaccination initiation are well
established, it is unclear whether these disparities have changed over time. The role of …

Importance Despite availability of safe and effective human papillomavirus (HPV) vaccines,
vaccination uptake remains low in the US Research examining the impact of neighborhood …

Recent studies have revealed that HPV vaccine uptake in the US is lower than desired. This
low coverage can predispose adolescents to high incidence of genital warts, and various …

HPV vaccine uptake in young adult women in the Southern US has been previously found to
be the lowest in the country. In addition, geographic variation with regard to HPV vaccination …

Background: Approximately 46,000 cases of human papillomavirus (HPV) attributable
cancers are diagnosed annually in the United States. The HPV vaccine can prevent over …

Background One of the goals of the President's Cancer Panel was to maximize access to
human papillomavirus (HPV) vaccination through expansion of alternative settings for …

Abstract Background/Objectives: The United States has experienced modest increase in
HPV vaccination uptake in the last decade, but remain short of the goal of vaccinating 80 …